These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11179523)

  • 1. Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment.
    Hecht HS; Superko HR; Smith LK; McColgan BP
    Am J Cardiol; 2001 Feb; 87(4):406-12. PubMed ID: 11179523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women.
    Hecht HS; Superko HR
    J Am Coll Cardiol; 2001 May; 37(6):1506-11. PubMed ID: 11345357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification.
    Superko HR; Hecht HS
    Am J Cardiol; 2001 Aug; 88(3):260-4. PubMed ID: 11472704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
    Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS
    Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
    Hodis HN; Mack WJ; Azen SP; Alaupovic P; Pogoda JM; LaBree L; Hemphill LC; Kramsch DM; Blankenhorn DH
    Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of coronary calcium progression and control of lipids according to National Cholesterol Education Program guidelines.
    Wong ND; Kawakubo M; LaBree L; Azen SP; Xiang M; Detrano R
    Am J Cardiol; 2004 Aug; 94(4):431-6. PubMed ID: 15325924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of Fasting Triglyceride-Rich Lipoprotein Cholesterol to Coronary Artery Calcium Score (from the ELSA-Brasil Study).
    Bittencourt MS; Santos RD; Staniak H; Sharovsky R; Kondapally R; Vallejo-Vaz AJ; Ray KK; Bensenor I; Lotufo P
    Am J Cardiol; 2017 May; 119(9):1352-1358. PubMed ID: 28302272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
    Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
    JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals.
    Orakzai SH; Nasir K; Blaha M; Blumenthal RS; Raggi P
    Atherosclerosis; 2009 Jan; 202(1):289-95. PubMed ID: 18452924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The lipid profile and coronary artery disease].
    Ladeia AM; Guimarães AC; Lima JC
    Arq Bras Cardiol; 1994 Aug; 63(2):101-6. PubMed ID: 7661704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma homocysteine predicts progression of atherosclerosis.
    Rasouli ML; Nasir K; Blumenthal RS; Park R; Aziz DC; Budoff MJ
    Atherosclerosis; 2005 Jul; 181(1):159-65. PubMed ID: 15939068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of serum high-density lipoprotein cholesterol levels for diagnosis of coronary stenosis as determined by MDCT in patients with suspected coronary artery disease.
    Shiga Y; Miura S; Mitsutake R; Kawamura A; Uehara Y; Saku K
    J Atheroscler Thromb; 2010 Aug; 17(8):870-8. PubMed ID: 20467190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
    Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
    Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
    Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R
    Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation.
    Achenbach S; Ropers D; Pohle K; Leber A; Thilo C; Knez A; Menendez T; Maeffert R; Kusus M; Regenfus M; Bickel A; Haberl R; Steinbeck G; Moshage W; Daniel WG
    Circulation; 2002 Aug; 106(9):1077-82. PubMed ID: 12196332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elevated HDL is the main negative risk factor for coronary artery disease in the elderly patient with calcific aortic valve disease].
    Bordalo AD; Nobre AL; Dantas M; Cravino J
    Rev Port Cardiol; 2012 Jun; 31(6):415-24. PubMed ID: 22609029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emphasis on high-density lipoprotein cholesterol in patients with coronary artery disease.
    Mailander L; Lavie CJ; Milani RV; Gaudin D
    South Med J; 1993 May; 86(5):508-12. PubMed ID: 8488395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of aggressiveness of lipid-lowering treatment to changes in calcified plaque burden by electron beam tomography.
    Hecht HS; Harman SM
    Am J Cardiol; 2003 Aug; 92(3):334-6. PubMed ID: 12888149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.